Meropenem Dosing Recommendations in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy

20260 citationsJournal Article

Authors

Jirapat Vamananda · Chulalongkorn University

Weerachai Chaijamorn · Chulalongkorn University

Taniya Charoensareerat · Siam University

Dhakrit Rungkitwattanakul · Howard University

Sutthiporn Pattharachayakul · Prince of Songkla University

Apinya Boonpeng · University of Phayao

Tatta Sriboonruang

Abstract

Optimized daily meropenem doses of 2000-3000 mg for PIRRT are recommended to ensure safe and effective outcomes, though further clinical validation is needed before widespread use.

Topics & Keywords

Antibiotics Pharmacokinetics and Efficacy Acute Kidney Injury Research Dialysis and Renal Disease Management

Publication Details

Published in: Nephrology

Volume 31, Issue 4, pp. e70196-e70196

DOI: 10.1111/nep.70196

Field-Weighted Citation Impact: 0.00

Command Palette

Meropenem Dosing Recommendations in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy

Authors

Abstract

Topics & Keywords

Publication Details